FACULTAD DE FARMACIA
Facultad
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (41)
2022
-
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919
-
Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study
Medicine (United States), Vol. 101, Núm. 42, pp. E31175
2021
-
Engraftment characterization of risk-stratified AML in NSGS mice
Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854
-
Environmental exposure during pregnancy: Influence on prenatal development and early life: A comprehensive review
Fetal Diagnosis and Therapy, Vol. 48, Núm. 4, pp. 245-257
-
Follow-up care over 12months of patients with prostate cancer in Spain A multicenter prospective cohort study
Medicine (United States), Vol. 100, Núm. 47
-
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
Journal of Biomedical Science, Vol. 28, Núm. 1
-
Socio-Demographic Health Determinants Are Associated with Poor Prognosis in Spanish Patients Hospitalized with COVID-19
Journal of General Internal Medicine, Vol. 36, Núm. 12, pp. 3737-3742
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Factors associated with the number of drugs in darunavir/cobicistat regimens
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 208-214
-
The evolving microbiome from pregnancy to early infancy: A comprehensive review
Nutrients, Vol. 12, Núm. 1
2019
-
Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis
Haematologica, Vol. 104, Núm. 2, pp. e54-e58
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Scientific Reports, Vol. 9, Núm. 1
2018
-
Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations
PLoS ONE, Vol. 13, Núm. 1
-
Impact of a pharmaceutical care programme for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: A randomised controlled trial
European Journal of Hospital Pharmacy , Vol. 25, Núm. 5, pp. 274-280
2017
-
An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis
Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457
-
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes
Stem Cell Reports, Vol. 8, Núm. 6, pp. 1573-1586
-
Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 10, pp. 2850-2856
-
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
Targeted Oncology, Vol. 12, Núm. 1, pp. 19-35